Long-term prognostic value of myeloperoxidase on acute coronary syndrome: a meta-analysis.

[1]  J. Kubica,et al.  Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes , 2011, European journal of clinical investigation.

[2]  M. Dąbrowska,et al.  Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease , 2010, International journal of laboratory hematology.

[3]  C. Polanczyk,et al.  Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients , 2010, Coronary artery disease.

[4]  A. Becker,et al.  Relation of elevated levels of plasma myeloperoxidase to impaired myocardial microcirculation after reperfusion in patients with acute myocardial infarction. , 2010, The American journal of cardiology.

[5]  B. Lindahl,et al.  Myeloperoxidase is not useful for the early assessment of patients with chest pain. , 2010, Clinical biochemistry.

[6]  C. Polanczyk,et al.  Serial Analyses of C‐Reactive Protein and Myeloperoxidase in Acute Coronary Syndrome , 2009, Clinical cardiology.

[7]  G. Khoschsorur,et al.  Determination of myeloperoxidase in EDTA plasma: comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[8]  H. Yip,et al.  Level and prognostic value of serum myeloperoxidase in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[9]  C. Mueller,et al.  Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations. , 2008, Clinical chemistry.

[10]  Nader Rifai,et al.  Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. , 2008, European heart journal.

[11]  V. Cameron,et al.  Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. , 2007, Journal of the American College of Cardiology.

[12]  V. Chopra,et al.  Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. , 2007, The American journal of cardiology.

[13]  F. Apple,et al.  Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. , 2007, Clinical chemistry.

[14]  Zhizhong Li,et al.  [Clinical implications of relationship between myeloperoxidase and acute coronary syndromes]. , 2007, Zhonghua xin xue guan bing za zhi.

[15]  E. Topol,et al.  Redefining risk in acute coronary syndromes using molecular medicine. , 2007, Journal of the American College of Cardiology.

[16]  Sohail Q Khan,et al.  Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction , 2006, Heart.

[17]  Stanley L Hazen,et al.  ATVB in Focus Redox Mechanisms in Blood Vessels , 2005 .

[18]  Marlene Goormastic,et al.  Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans , 2004, Circulation.

[19]  S. Hazen.  Myeloperoxidase and plaque vulnerability. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[20]  C. Heeschen,et al.  Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes , 2003, Circulation.

[21]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[22]  David A Morrow,et al.  Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy , 2003, Circulation.

[23]  J. Heinecke.  Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. , 2003, The American journal of cardiology.

[24]  Kazuo Haze,et al.  Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes , 2002, Circulation.

[25]  S. Hazen,et al.  Myeloperoxidase-generated oxidants and atherosclerosis. , 2000, Free radical biology & medicine.

[26]  S. Hazen,et al.  Nitric Oxide Modulates the Catalytic Activity of Myeloperoxidase* , 2000, The Journal of Biological Chemistry.

[27]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[28]  A. Rebuzzi,et al.  Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. , 1996, Journal of the American College of Cardiology.

[29]  I. Menown,et al.  Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. , 2009, The American journal of cardiology.

[30]  H. Staines,et al.  The long-term prognostic value of multiple biomarkers following a myocardial infarction. , 2008, Thrombosis research.